Lexicon Pharmaceuticals, Inc. (LXRX)

USD 0.68

(-6.06%)

Revenue Summary of Lexicon Pharmaceuticals, Inc.

  • Lexicon Pharmaceuticals, Inc.'s latest annual revenue in 2023 was 1.2 Million USD , up 766.19% from previous year.
  • Lexicon Pharmaceuticals, Inc.'s latest quarterly revenue in 2024 Q2 was 1.64 Million USD , up 45.75% from previous quarter.
  • Lexicon Pharmaceuticals, Inc. reported a annual revenue of 139 Thousand USD in annual revenue 2022, down -53.36% from previous year.
  • Lexicon Pharmaceuticals, Inc. reported a annual revenue of 298 Thousand USD in annual revenue 2021, down -98.76% from previous year.
  • Lexicon Pharmaceuticals, Inc. reported a quarterly revenue of 1.64 Million USD for 2024 Q2, up 45.75% from previous quarter.
  • Lexicon Pharmaceuticals, Inc. reported a quarterly revenue of 1.2 Million USD for 2023 FY, up 766.19% from previous quarter.

Annual Revenue Chart of Lexicon Pharmaceuticals, Inc. (2023 - 1999)

Historical Annual Revenue of Lexicon Pharmaceuticals, Inc. (2023 - 1999)

Year Revenue Revenue Growth
2023 1.2 Million USD 766.19%
2022 139 Thousand USD -53.36%
2021 298 Thousand USD -98.76%
2020 23.99 Million USD -92.55%
2019 322.07 Million USD 409.54%
2018 63.2 Million USD -30.03%
2017 90.33 Million USD 8.4%
2016 83.33 Million USD -35.9%
2015 130.01 Million USD 468.89%
2014 22.85 Million USD 928.53%
2013 2.22 Million USD 104.04%
2012 1.08 Million USD -41.1%
2011 1.84 Million USD -62.33%
2010 4.9 Million USD -54.13%
2009 10.7 Million USD -66.89%
2008 32.32 Million USD -35.51%
2007 50.11 Million USD -31.15%
2006 72.79 Million USD -3.81%
2005 75.68 Million USD 22.58%
2004 61.74 Million USD 44.12%
2003 42.83 Million USD 21.7%
2002 35.2 Million USD -88.48%
2001 305.57 Million USD 2013.47%
2000 14.45 Million USD 207.63%
1999 4.7 Million USD 0.0%

Peer Revenue Comparison of Lexicon Pharmaceuticals, Inc.

Name Revenue Revenue Difference
Sangamo Therapeutics, Inc. 176.23 Million USD 99.317%
IDEAYA Biosciences, Inc. 23.38 Million USD 94.851%
Eton Pharmaceuticals, Inc. 31.64 Million USD 96.195%
Autolus Therapeutics plc 1.69 Million USD 29.093%
Greenwich LifeSciences, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
Shattuck Labs, Inc. 1.65 Million USD 27.339%
LENZ Therapeutics, Inc. - USD -Infinity%
CervoMed Inc. 7.14 Million USD 83.149%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
Aptose Biosciences Inc. - USD -Infinity%
Precision BioSciences, Inc. 48.72 Million USD 97.529%
Dyadic International, Inc. 2.89 Million USD 58.466%
TScan Therapeutics, Inc. 21.04 Million USD 94.28%
Intensity Therapeutics, Inc. - USD -Infinity%
Nektar Therapeutics 90.12 Million USD 98.664%
CytomX Therapeutics, Inc. 101.21 Million USD 98.81%
VYNE Therapeutics Inc. 424 Thousand USD -183.962%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 97.384%
Leap Therapeutics, Inc. - USD -Infinity%
Adaptive Biotechnologies Corporation 170.27 Million USD 99.293%
GRI Bio, Inc. 21.76 Million USD 94.469%
Xenetic Biosciences, Inc. 2.53 Million USD 52.598%
Tenaya Therapeutics, Inc. - USD -Infinity%
NeuroSense Therapeutics Ltd. - USD -Infinity%
Psyence Biomedical Ltd. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 43.474%
INmune Bio, Inc. 155 Thousand USD -676.774%
Opthea Limited 261.85 Thousand USD -359.789%
Milestone Pharmaceuticals Inc. 1 Million USD -20.4%
Omega Therapeutics, Inc. 3.09 Million USD 61.086%
Verastem, Inc. - USD -Infinity%
Abeona Therapeutics Inc. 3.5 Million USD 65.6%
Pliant Therapeutics, Inc. 1.58 Million USD 23.797%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 84.501%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 99.083%
NextCure, Inc. - USD -Infinity%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD -362.188%
Organovo Holdings, Inc. 109 Thousand USD -1004.587%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Arvinas, Inc. 78.5 Million USD 98.466%
Ovid Therapeutics Inc. 391.69 Thousand USD -207.382%
CASI Pharmaceuticals, Inc. 33.87 Million USD 96.446%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 82.431%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 99.237%
Syros Pharmaceuticals, Inc. 9.93 Million USD 87.882%
Senti Biosciences, Inc. 2.56 Million USD 52.987%
BioRestorative Therapies, Inc. 145.8 Thousand USD -725.789%
Apollomics, Inc. 821 Thousand USD -46.65%
PureTech Health plc 3.33 Million USD 63.844%
Oncternal Therapeutics, Inc. 785 Thousand USD -53.376%
Barinthus Biotherapeutics plc 802 Thousand USD -50.125%
Kymera Therapeutics, Inc. 78.59 Million USD 98.468%
Synaptogenix, Inc. - USD -Infinity%
ChromaDex Corporation 83.57 Million USD 98.559%
Beam Therapeutics Inc. 377.7 Million USD 99.681%
Monopar Therapeutics Inc. - USD -Infinity%
Akebia Therapeutics, Inc. 194.62 Million USD 99.381%
Nurix Therapeutics, Inc. 76.98 Million USD 98.436%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.696%
Dermata Therapeutics, Inc. - USD -Infinity%
Gritstone bio, Inc. 1.33 Million USD 9.542%
Mesoblast Limited 5.9 Million USD 79.6%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.265%
Fate Therapeutics, Inc. 63.53 Million USD 98.105%
MediWound Ltd. 18.68 Million USD 93.557%
BioXcel Therapeutics, Inc. 1.38 Million USD 12.754%
Fortress Biotech, Inc. 84.51 Million USD 98.575%
Fractyl Health, Inc. Common Stock 120 Thousand USD -903.333%
Achilles Therapeutics plc - USD -Infinity%
Seres Therapeutics, Inc. 126.32 Million USD 99.047%
Checkpoint Therapeutics, Inc. 103 Thousand USD -1068.932%
Atossa Therapeutics, Inc. - USD -Infinity%
Zai Lab Limited 266.71 Million USD 99.549%
Fresh Tracks Therapeutics, Inc. 8 Million USD 84.961%
Lyell Immunopharma, Inc. 130 Thousand USD -826.154%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.375%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 93.099%
InMed Pharmaceuticals Inc. 4.59 Million USD 73.813%
FibroGen, Inc. 147.75 Million USD 99.185%
Celcuity Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
ContextLogic Inc. 287 Million USD 99.58%
GH Research PLC - USD -Infinity%
HOOKIPA Pharma Inc. 20.12 Million USD 94.019%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD -186.667%
ImmuCell Corporation 17.47 Million USD 93.109%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.684%
Amarin Corporation plc 306.91 Million USD 99.608%
TG Therapeutics, Inc. 233.66 Million USD 99.485%
Aptevo Therapeutics Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
Foghorn Therapeutics Inc. 34.15 Million USD 96.475%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 98.581%
Aptorum Group Limited 431.37 Thousand USD -179.106%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.723%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.637%
Chemomab Therapeutics Ltd. - USD -Infinity%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.5%
TransCode Therapeutics, Inc. - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Ardelyx, Inc. 124.45 Million USD 99.033%
Ainos, Inc. 122.11 Thousand USD -885.98%
Lyra Therapeutics, Inc. 1.55 Million USD 22.721%
Prothena Corporation plc 91.37 Million USD 98.682%
HilleVax, Inc. - USD -Infinity%
Adaptimmune Therapeutics plc 60.28 Million USD 98.003%
Celularity Inc. 22.77 Million USD 94.713%
Rallybio Corporation - USD -Infinity%
Cue Biopharma, Inc. 5.49 Million USD 78.069%
Omeros Corporation - USD -Infinity%
Humacyte, Inc. - USD -Infinity%
Immunocore Holdings plc 249.42 Million USD 99.517%
Cocrystal Pharma, Inc. - USD -Infinity%
Blueprint Medicines Corporation 249.38 Million USD 99.517%
IO Biotech, Inc. - USD -Infinity%
MEI Pharma, Inc. 65.29 Million USD 98.156%
GT Biopharma, Inc. - USD -Infinity%
Cabaletta Bio, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Alaunos Therapeutics, Inc. 5000.00 USD -23980.0%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 96.115%
Scholar Rock Holding Corporation - USD -Infinity%
Pulmatrix, Inc. 7.29 Million USD 83.502%
Elicio Therapeutics, Inc. - USD -Infinity%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Vigil Neuroscience, Inc. - USD -Infinity%
Acelyrin, Inc. - USD -Infinity%
Intellia Therapeutics, Inc. 36.27 Million USD 96.681%
Cytokinetics, Incorporated 7.53 Million USD 84.011%
Vor Biopharma Inc. - USD -Infinity%
Evogene Ltd. 5.64 Million USD 78.652%
Replimune Group, Inc. - USD -Infinity%
Applied Therapeutics, Inc. 9.99 Million USD 87.952%
PDS Biotechnology Corporation - USD -Infinity%
Hoth Therapeutics, Inc. - USD -Infinity%
BridgeBio Pharma, Inc. 9.3 Million USD 87.058%
AEON Biopharma, Inc. - USD -Infinity%
BioLineRx Ltd. 4.8 Million USD 74.917%
Galectin Therapeutics Inc. - USD -Infinity%
Atai Life Sciences N.V. 314 Thousand USD -283.439%
Aerovate Therapeutics, Inc. - USD -Infinity%
VistaGen Therapeutics, Inc. 1.06 Million USD -13.158%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
Sagimet Biosciences Inc. 2 Million USD 39.8%
MediciNova, Inc. 1 Million USD -20.4%
Praxis Precision Medicines, Inc. 2.44 Million USD 50.797%
MiMedx Group, Inc. 321.47 Million USD 99.625%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -6955.377%
Axsome Therapeutics, Inc. 270.6 Million USD 99.555%
PTC Therapeutics, Inc. 937.82 Million USD 99.872%
Mereo BioPharma Group plc 10 Million USD 87.96%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Dyne Therapeutics, Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Allakos Inc. - USD -Infinity%
scPharmaceuticals Inc. 13.59 Million USD 91.142%
Fulcrum Therapeutics, Inc. 2.8 Million USD 57.077%
Corcept Therapeutics Incorporated 482.37 Million USD 99.75%
NLS Pharmaceutics AG - USD -Infinity%
Precigen, Inc. 6.22 Million USD 80.659%
XOMA Corporation 4.75 Million USD 74.695%
Kezar Life Sciences, Inc. 7 Million USD 82.8%
Incyte Corporation 3.69 Billion USD 99.967%
Alzamend Neuro, Inc. - USD -Infinity%
Cara Therapeutics, Inc. 20.96 Million USD 94.258%
Aligos Therapeutics, Inc. 15.52 Million USD 92.247%
Seer, Inc. 15.18 Million USD 92.07%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
CRISPR Therapeutics AG 371.2 Million USD 99.676%
Akero Therapeutics, Inc. - USD -Infinity%
Eliem Therapeutics, Inc. - USD -Infinity%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -9884.244%
Akari Therapeutics, Plc - USD -Infinity%
Novavax, Inc. 983.7 Million USD 99.878%
Lexaria Bioscience Corp. 226.2 Thousand USD -432.254%
UroGen Pharma Ltd. 82.71 Million USD 98.544%
Sutro Biopharma, Inc. 153.73 Million USD 99.217%
Entera Bio Ltd. - USD -Infinity%
Lisata Therapeutics, Inc. - USD -Infinity%
Stoke Therapeutics, Inc. 8.78 Million USD 86.287%
Chimerix, Inc. 324 Thousand USD -271.605%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Phathom Pharmaceuticals, Inc. 682 Thousand USD -76.54%
Outlook Therapeutics, Inc. - USD -Infinity%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.969%
AnaptysBio, Inc. 17.15 Million USD 92.982%
Aprea Therapeutics, Inc. 583.23 Thousand USD -106.436%
Portage Biotech Inc. - USD -Infinity%
Olema Pharmaceuticals, Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Qualigen Therapeutics, Inc. 5.2 Million USD 76.867%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Processa Pharmaceuticals, Inc. - USD -Infinity%
AbCellera Biologics Inc. 38.02 Million USD 96.834%
Genprex, Inc. - USD -Infinity%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
Daré Bioscience, Inc. 2.8 Million USD 57.121%
Titan Pharmaceuticals, Inc. 184 Thousand USD -554.348%
Bicycle Therapeutics plc 26.97 Million USD 95.537%
Revolution Medicines, Inc. Warrant 11.58 Million USD 89.603%
Protagonist Therapeutics, Inc. 60 Million USD 97.993%
Erasca, Inc. - USD -Infinity%
bluebird bio, Inc. 29.49 Million USD 95.918%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 97.188%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.95%
DBV Technologies S.A. 15.72 Million USD 92.345%
Fortress Biotech, Inc. 84.51 Million USD 98.575%
Avidity Biosciences, Inc. 9.56 Million USD 87.406%
CorMedix Inc. - USD -Infinity%
Travere Therapeutics, Inc. 145.23 Million USD 99.171%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 56.377%
Spruce Biosciences, Inc. 10.08 Million USD 88.066%
Celldex Therapeutics, Inc. 6.88 Million USD 82.508%
Cartesian Therapeutics, Inc. 26 Million USD 95.37%
Cogent Biosciences, Inc. - USD -Infinity%
Onconetix, Inc. 58.46 Thousand USD -1959.352%
Ocuphire Pharma, Inc. 19.04 Million USD 93.679%
Prime Medicine, Inc. - USD -Infinity%
Adagene Inc. 18.11 Million USD 93.352%
Inhibrx Biosciences, Inc. 1.8 Million USD 33.111%
GlycoMimetics, Inc. 10 Thousand USD -11940.0%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.583%
Verve Therapeutics, Inc. 11.75 Million USD 89.76%
Voyager Therapeutics, Inc. 250 Million USD 99.518%
SciSparc Ltd. 2.87 Million USD 58.18%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. - USD -Infinity%
Astria Therapeutics, Inc. - USD -Infinity%
Spero Therapeutics, Inc. 96.73 Million USD 98.755%
Tevogen Bio Holdings Inc. - USD -Infinity%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 97.98%
Marker Therapeutics, Inc. 3.31 Million USD 63.638%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.934%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 98.801%
ADMA Biologics, Inc. 258.21 Million USD 99.534%
Clene Inc. 654 Thousand USD -84.098%
Capricor Therapeutics, Inc. 25.17 Million USD 95.218%
Boundless Bio, Inc. Common Stock - USD -Infinity%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 97.299%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 97.592%
Absci Corporation 5.71 Million USD 78.944%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 99.991%
Surrozen, Inc. - USD -Infinity%
Caribou Biosciences, Inc. 34.47 Million USD 96.508%
Janux Therapeutics, Inc. 8.08 Million USD 85.105%
Cingulate Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Jaguar Health, Inc. 9.76 Million USD 87.665%
Terns Pharmaceuticals, Inc. - USD -Infinity%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.834%
Kronos Bio, Inc. 6.28 Million USD 80.852%
Innoviva, Inc. 310.46 Million USD 99.612%
Bolt Biotherapeutics, Inc. 7.87 Million USD 84.713%
Entrada Therapeutics, Inc. 129.01 Million USD 99.067%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD -43.443%
AlloVir, Inc. - USD -Infinity%
Century Therapeutics, Inc. 2.23 Million USD 46.13%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
Kura Oncology, Inc. - USD -Infinity%
Ocean Biomedical, Inc. - USD -Infinity%
Mineralys Therapeutics, Inc. - USD -Infinity%
Eterna Therapeutics Inc. 68 Thousand USD -1670.588%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Heron Therapeutics, Inc. 127.04 Million USD 99.052%
SAB Biotherapeutics, Inc. 2.23 Million USD 46.226%
Pasithea Therapeutics Corp. - USD -Infinity%
Entero Therapeutics, Inc. - USD -Infinity%
HCW Biologics Inc. 2.84 Million USD 57.632%
C4 Therapeutics, Inc. 20.75 Million USD 94.199%
Atara Biotherapeutics, Inc. 8.57 Million USD 85.956%
Coherus BioSciences, Inc. 257.24 Million USD 99.532%
Lantern Pharma Inc. - USD -Infinity%
Histogen Inc. 3.76 Million USD 68.055%
Surrozen, Inc. - USD -Infinity%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
Kodiak Sciences Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
Adverum Biotechnologies, Inc. 3.6 Million USD 66.556%
Avalo Therapeutics, Inc. 1.92 Million USD 37.422%
Moderna, Inc. 6.84 Billion USD 99.982%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.847%
Turnstone Biologics Corp. 19.3 Million USD 93.764%
Immix Biopharma, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 99.314%
Exelixis, Inc. 1.83 Billion USD 99.934%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Wave Life Sciences Ltd. 113.3 Million USD 98.937%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Alkermes plc 1.66 Billion USD 99.928%
Jasper Therapeutics, Inc. - USD -Infinity%
Arcellx, Inc. 110.31 Million USD 98.909%
ESSA Pharma Inc. - USD -Infinity%
TNF Pharmaceuticals, Inc. - USD -Infinity%
Avid Bioservices, Inc. 139.91 Million USD 99.139%
Insmed Incorporated 305.2 Million USD 99.606%
Cardiff Oncology, Inc. 488 Thousand USD -146.721%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 98.48%
Moolec Science SA 905.04 Thousand USD -33.031%
RenovoRx, Inc. - USD -Infinity%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
Geron Corporation 237 Thousand USD -408.017%
LAVA Therapeutics N.V. 6.76 Million USD 82.213%
Verrica Pharmaceuticals Inc. 5.12 Million USD 76.503%
Royalty Pharma plc 2.35 Billion USD 99.949%
OmniAb, Inc. 34.16 Million USD 96.476%
Alector, Inc. 97.06 Million USD 98.76%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Mersana Therapeutics, Inc. 36.85 Million USD 96.733%
Humacyte, Inc. - USD -Infinity%
Structure Therapeutics Inc. - USD -Infinity%
Revance Therapeutics, Inc. 234.04 Million USD 99.486%
89bio, Inc. - USD -Infinity%
Avenue Therapeutics, Inc. - USD -Infinity%
Aura Biosciences, Inc. - USD -Infinity%
Immunic, Inc. - USD -Infinity%
Veracyte, Inc. 361.05 Million USD 99.667%
Genelux Corporation 170 Thousand USD -608.235%
Trevi Therapeutics, Inc. - USD -Infinity%
Adial Pharmaceuticals, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD -714.587%
Immunovant, Inc. - USD -Infinity%
Vericel Corporation 197.51 Million USD 99.39%
Fortrea Holdings Inc. 3.1 Billion USD 99.961%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
XBiotech Inc. - USD -Infinity%
Agenus Inc. 156.31 Million USD 99.23%
Acasti Pharma Inc. - USD -Infinity%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. - USD -Infinity%
Theravance Biopharma, Inc. 57.42 Million USD 97.903%
Metagenomi, Inc. Common Stock 44.75 Million USD 97.31%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
Gain Therapeutics, Inc. 55.18 Thousand USD -2081.95%
Tempest Therapeutics, Inc. - USD -Infinity%
Sol-Gel Technologies Ltd. 1.55 Million USD 22.523%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 98.445%
United Therapeutics Corporation 2.32 Billion USD 99.948%
Creative Medical Technology Holdings, Inc. 9000.00 USD -13277.778%
BriaCell Therapeutics Corp. - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD -1569.857%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.509%
XOMA Corporation 4.75 Million USD 74.695%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Bionomics Limited - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
Pyxis Oncology, Inc. - USD -Infinity%
uniQure N.V. 15.84 Million USD 92.4%
Xilio Therapeutics, Inc. - USD -Infinity%
Cassava Sciences, Inc. - USD -Infinity%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD -374.814%
Windtree Therapeutics, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 98.139%
Pluri Inc. 326 Thousand USD -269.325%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
MeiraGTx Holdings plc 14.01 Million USD 91.41%
Cidara Therapeutics, Inc. 63.9 Million USD 98.116%
ProMIS Neurosciences, Inc. - USD -Infinity%
CalciMedica, Inc. - USD -Infinity%
Sana Biotechnology, Inc. - USD -Infinity%
Amicus Therapeutics, Inc. 399.35 Million USD 99.699%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 75.899%
Nutriband Inc. 2.08 Million USD 42.263%
Protara Therapeutics, Inc. - USD -Infinity%
Compugen Ltd. 33.45 Million USD 96.402%
Roivant Sciences Ltd. 124.79 Million USD 99.035%
ProKidney Corp. - USD -Infinity%
Protagenic Therapeutics, Inc. - USD -Infinity%
Elevai Labs, Inc. Common Stock 1.71 Million USD 29.697%
Tango Therapeutics, Inc. 36.52 Million USD 96.704%
Renovaro Biosciences Inc. - USD -Infinity%
Zevra Therapeutics, Inc. 27.46 Million USD 95.616%
Benitec Biopharma Inc. 216 Thousand USD -457.407%
GeoVax Labs, Inc. - USD -Infinity%
Biomea Fusion, Inc. - USD -Infinity%
Cullinan Oncology, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 94.19%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.555%
Nuvectis Pharma, Inc. - USD -Infinity%
Spyre Therapeutics, Inc. 886 Thousand USD -35.892%
Ventyx Biosciences, Inc. - USD -Infinity%
Imunon, Inc. - USD -Infinity%
BioAtla, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD -1167.368%
Larimar Therapeutics, Inc. - USD -Infinity%
Zura Bio Limited - USD -Infinity%
aTyr Pharma, Inc. 353 Thousand USD -241.076%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
Viridian Therapeutics, Inc. 314 Thousand USD -283.439%
Galecto, Inc. - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.855%
PolyPid Ltd. - USD -Infinity%
Aileron Therapeutics, Inc. - USD -Infinity%
Forte Biosciences, Inc. - USD -Infinity%
Xencor, Inc. 168.33 Million USD 99.285%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Lexaria Bioscience Corp. 226.2 Thousand USD -432.254%
Instil Bio, Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -6955.377%
OncoCyte Corporation 1.5 Million USD 19.894%
Elevation Oncology, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
CollPlant Biotechnologies Ltd. 10.95 Million USD 89.014%
MacroGenics, Inc. 58.74 Million USD 97.951%
Verona Pharma plc - USD -Infinity%
Tharimmune, Inc. - USD -Infinity%
Apogee Therapeutics, Inc. - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Aditxt, Inc. 645.17 Thousand USD -86.616%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Savara Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 87.988%
Carmell Therapeutics Corporation - USD -Infinity%
Achieve Life Sciences, Inc. - USD -Infinity%
BeiGene, Ltd. 2.45 Billion USD 99.951%
Protagenic Therapeutics, Inc. - USD -Infinity%
Vincerx Pharma, Inc. - USD -Infinity%
Plus Therapeutics, Inc. 4.91 Million USD 75.494%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 98.97%
Adicet Bio, Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD -11.275%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Generation Bio Co. 5.9 Million USD 79.607%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Invivyd, Inc. - USD -Infinity%
Relay Therapeutics, Inc. 25.54 Million USD 95.287%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Moolec Science SA 905.04 Thousand USD -33.031%
Clearside Biomedical, Inc. 8.22 Million USD 85.363%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
Relmada Therapeutics, Inc. - USD -Infinity%
ALX Oncology Holdings Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 98.603%
Evaxion Biotech A/S 73.11 Thousand USD -1546.788%
Ocular Therapeutix, Inc. 58.44 Million USD 97.94%
Tyra Biosciences, Inc. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
Aadi Bioscience, Inc. 24.35 Million USD 95.056%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.698%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Keros Therapeutics, Inc. 151 Thousand USD -697.351%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 69.998%
ImmunityBio, Inc. 622 Thousand USD -93.569%
Korro Bio, Inc. - USD -Infinity%
Kineta, Inc. 5.44 Million USD 77.876%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 98.284%
Celularity Inc. 22.77 Million USD 94.713%
Virax Biolabs Group Limited 156.41 Thousand USD -669.727%
Cibus, Inc. 1.81 Million USD 33.737%
Annexon, Inc. - USD -Infinity%
Assembly Biosciences, Inc. 7.16 Million USD 83.191%
Eyenovia, Inc. 3787.00 USD -31692.976%
Puma Biotechnology, Inc. 235.63 Million USD 99.489%
NeurAxis, Inc. 2.46 Million USD 51.058%
Regulus Therapeutics Inc. - USD -Infinity%
Compass Therapeutics, Inc. - USD -Infinity%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD -64.062%
Notable Labs, Ltd. 310 Thousand USD -288.387%
IN8bio, Inc. - USD -Infinity%
DiaMedica Therapeutics Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 35.338%
Lumos Pharma, Inc. 2.05 Million USD 41.297%
Liquidia Corporation 17.48 Million USD 93.115%
Mustang Bio, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD -11.275%
Arbutus Biopharma Corporation 18.14 Million USD 93.363%
enGene Holdings Inc. Common Stock - USD -Infinity%
ARS Pharmaceuticals, Inc. 30 Thousand USD -3913.333%
180 Life Sciences Corp. - USD -Infinity%
Vaxcyte, Inc. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
NKGen Biotech, Inc. Warrants - USD -Infinity%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 97.044%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Soleno Therapeutics, Inc. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Moleculin Biotech, Inc. - USD -Infinity%
Solid Biosciences Inc. - USD -Infinity%
Palisade Bio, Inc. 250 Thousand USD -381.6%
Nutriband Inc. 2.08 Million USD 42.263%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Belite Bio, Inc - USD -Infinity%
CG Oncology, Inc. Common stock 204 Thousand USD -490.196%
GeoVax Labs, Inc. - USD -Infinity%
Tourmaline Bio, Inc. - USD -Infinity%
Altimmune, Inc. 426 Thousand USD -182.629%
Peak Bio, Inc. 367.87 Thousand USD -227.283%
SeaStar Medical Holding Corporation - USD -Infinity%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Neurogene Inc. - USD -Infinity%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.354%
Kintara Therapeutics, Inc. - USD -Infinity%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 96.99%
argenx SE 1.22 Billion USD 99.902%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Dianthus Therapeutics, Inc. 2.82 Million USD 57.396%
Immunome, Inc. 14.01 Million USD 91.411%
Enveric Biosciences, Inc. - USD -Infinity%
Design Therapeutics, Inc. - USD -Infinity%
Seelos Therapeutics, Inc. 2.2 Million USD 45.347%
Enliven Therapeutics, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 1.18 Million USD -1.262%
Taysha Gene Therapies, Inc. 15.45 Million USD 92.208%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD -44.71%
Athira Pharma, Inc. - USD -Infinity%
XOMA Corporation 4.75 Million USD 74.695%
Merus N.V. 43.94 Million USD 97.26%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD -84.098%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD 31.239%
Synlogic, Inc. 3.37 Million USD 64.284%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD -227.283%
Werewolf Therapeutics, Inc. 19.94 Million USD 93.963%
Krystal Biotech, Inc. 50.69 Million USD 97.625%
Karyopharm Therapeutics Inc. 146.03 Million USD 99.176%
SpringWorks Therapeutics, Inc. 5.44 Million USD 77.896%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD -167.783%
MannKind Corporation 198.96 Million USD 99.395%
Ikena Oncology, Inc. 9.16 Million USD 86.856%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 98.939%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.578%
Mural Oncology plc - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 97.599%
REGENXBIO Inc. 90.24 Million USD 98.666%
Ensysce Biosciences, Inc. 2.23 Million USD 46.022%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 83.683%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD -59.47%
Longeveron Inc. 709 Thousand USD -69.817%
Repare Therapeutics Inc. 51.13 Million USD 97.645%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.903%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 89.603%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD -473.333%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 99.988%
Denali Therapeutics Inc. 330.53 Million USD 99.636%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 92.612%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 55.457%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD -689.871%
Carisma Therapeutics, Inc. 14.91 Million USD 91.93%
Unicycive Therapeutics, Inc. 675 Thousand USD -78.37%
OmniAb, Inc. 34.16 Million USD 96.476%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 94.335%
Lipocine Inc. -2.85 Million USD 142.233%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 46.226%
G1 Therapeutics, Inc. 82.51 Million USD 98.541%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 98.607%
Ocugen, Inc. 6.03 Million USD 80.053%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Q32 Bio Inc. 1.15 Million USD -4.152%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 96.663%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 79.941%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Dominari Holdings Inc. 2.03 Million USD 40.951%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.896%
Agios Pharmaceuticals, Inc. 26.82 Million USD 95.511%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.793%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 90.441%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD -152.411%
Iterum Therapeutics plc - USD -Infinity%